Ayush Ministry Asks Patanjali to Stop Promoting COVID Vaccine

Ayush Ministry Asks Patanjali to Stop Promoting COVID Vaccine, Latest Vaccine News, Corona, India News, Latest News, Patanjali, Coronil Tablet
Ayush Ministry Asks Patanjali to Stop Promoting COVID Vaccine

Earlier on Tuesday, Patanjali had claimed that they have possibly found a cure to the novel coronavirus and introduced Coronil Tablet. But hours after its announcement, Ayush ministry directed the company to stop promoting or advertising the product as such claims should be duly verified before releasing to the market.

In a statement, the ministry said “In order to make this ministry aware of the facts of the aforesaid news and verify the claims, Patanjali Ayurveda has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for Covid-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results in data of the study,”

The ministry does not know the scientific study of these tablets, hence they asked the company to stop promoting.

Priced at Rs 545, Patanjali claimed a series of Ayurvedic medicines Swasari Vati, Coronil tablet and Anu Taila which they say has a proven efficiency to treat the novel coronavirus which is growing at a pace in India.

Baba Ramdev said that the Coronil Tablets and other Ayurvedic medicines used to administer has shown 100% efficiency where the test was conducted to over 280 patients. Out of 280 over 95% of patients recovered in 3 days and the rest within 7 days. There were no deaths reported.

“The medicines have a 100% recovery rate within three to seven days,” he said.

Patanjali had planned to distribute the medicine kit to all stores within 2 weeks and also planned to introduce an application for helping the online sale of the product.

The ministry of Ayush has also requested the concerned state licensing authority of the Uttarakhand government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of Covid-19.